Skip to main content

Animations

MJFF Publications

8251 - 8260 of 8808 Results
Title
Year
  • Year
  • 2023
  • 2025
  • 2024
  • 2021
  • 2019
  • 2019
  • 2023
  • 2015
  • 2024
  • 2015
  • Summary Details
    OPEN
    Title: Expert Consensus on the Use of On‐Demand Treatments for OFF Episodes in Parkinson's Disease: A Modified Delphi Panel
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mdc3.13690
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Autoantibodies against α-synuclein inhibit its aggregation and cytotoxicity
    Journal Name: Journal of Autoimmunity
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.jaut.2025.103390
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Hope vs. Hype II: It is time to offer pre-symptomatic genetic testing for GBA and LRRK2 variants
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107041
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Differentially expressed genes in Alzheimer’s disease highlighting the roles of microglia genes including OLR1 and astrocyte gene CDK2AP1
    Journal Name: Brain, Behavior, & Immunity - Health
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.bbih.2021.100227
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Predicting severity and prognosis in Parkinson's disease from brain microstructure and connectivity
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2019.102111
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Systemic Exosomal Delivery of shRNA Minicircles Prevents Parkinsonian Pathology
    Journal Name: Molecular Therapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ymthe.2019.08.010
    Citation Count: 182
  • Summary Details
    RESTRICTED
    Title: Transdermal Nicotine Treatment and Progression of Early Parkinson’s Disease
    Journal Name: NEJM Evidence
    Publisher: Massachusetts Medical Society
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1056/evidoa2200311
    Citation Count: 19
  • Summary Details
    OPEN
    Title: The Discovery of Central Nervous System Lymphatic Vessels: The Missing Link That Closes the Circle of Brain Immunosurveillance
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12282
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Neural heterogeneity controls computations in spiking neural networks
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2311885121
    Citation Count: 59
  • Summary Details
    OPEN
    Title: Microglial P2Y12 receptors regulate microglial activation and surveillance during neuropathic pain
    Journal Name: Brain, Behavior, and Immunity
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbi.2015.11.007
    Citation Count: 122
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.